Biosimilar ranibizumab in India- overview of phase 3 clinical trial designs

Ashish Sharma*, Nilesh Kumar, Nikulaa Parachuri, Francesco Bandello, Anat Loewenstein, Baruch D. Kuppermann

*Corresponding author for this work

Research output: Contribution to journalComment/debate

Original languageEnglish
JournalEye
DOIs
StateAccepted/In press - 2024

Funding

FundersFunder number
Gavin Herbert Eye Institute at the University of California, Irvine
Research to Prevent Blindness

    Cite this